Media-OutReach Newswire
, Deiveson Figueiredo (second from the right), Yan Xiaonan (first from the left) and Tabatha Ricci (first from the right) were in attendance to spea)
Ba Den Mountain – A pilgrimage to the sacred land
1.
TRIESENBERG, LIECHTENSTEIN - EQS Newswire - September 16th2019 - Lysando AG, market leader forantimicrobial proteins based in Liechtenstein, establishes an Ethical Committee,composed of two renowned members, who will serve on a voluntary basis, LeonhardStärk and Dr. Karl Liese. The committee has been tasked to advise and supportthe Company's ethnical strategy, specifically with regard to the introductionof Artilysin® for general benefit.
The market leader for antimicrobial proteins, Lysando AG, who recentlysigned a license contract with the anti-infectives company AiCuris Anti-infectiveCures GmbH, now establishes an Ethical Committee. Leonhard Stärk, regionalmanager of the Bavarian Red Cross and Dr. Karl Liese, Senior Partner for GlobalHealthcare with McKinsey & Company, will advise Lysando on its ethicalstrategies and procedures.
The Artilysin® technology is a new class of molecules with a physicalmode of action for a specific elimination of disease-causing bacteria.Artilysin®s stand out due to their high resistance stability, eco-friendlinessand microbiome compatibility. Lysando has already introduced Artilysin®sagainst highly-resistant germs and has established it in several indications.
More than 100 million people are estimated to be infected bygonorrhea each year, worldwide. Most contagions take place in third worldcountries and thus, the pharma industry does not have a valid business model.Lysando, however, has developed a resistance stable Artilysin® to fight gonorrhea,which can end the humanitarian need. The Ethical Committee will support Lysandoto make this Artilysin® accessible to patients in these affected regions. Theywill additionally hold talks with relevant politicians and foundations.
Leonhard Stärk: „I understand Lysando's motivation well. Helpingpeople is the heart of the Red Cross's philosophy. Solely, Lysando will not beable to confront this global problem, which is why I am proud to support thissmall, but highly-innovative research company, in addition to my other workobligations. I am thrilled by the opportunity to volunteer my time to Lysando."
Dr. Karl Liese: „You do not have to search abroad. In Europe thereare also exceptional high-performance and innovative companies. If they thenneed advice to help others on a pro bono basis, then it goes without saying, Isupport this cause."
